English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Aug 8, 2025

PhRMA Chief Public Affairs Officer on 340B abuse: ‘Big, tax-exempt hospitals in urban areas are using a loophole to qualify as “rural”’
Patient Daily | Aug 7, 2025

Dallas Breathe Free Sinus & Allergy Centers earns 4.8-star rating from 670 Google reviews
+ Pharmaceuticals
Patient Daily | Aug 5, 2025

Melina R. Kibbe named president of UTHealth Houston
+ Pharmaceuticals
Patient Daily | Aug 5, 2025

Fort Bend County survey finds major gaps in mental health and prenatal care access
+ Pharmaceuticals
Patient Daily | Aug 5, 2025

UtHealth Houston neurosurgical team enables patient’s return to aerobatic flight after rare brain bypass
+ Pharmaceuticals
Patient Daily | Aug 5, 2025

American Lung Association study urges schools to prioritize clean classroom air
Patient Daily | Aug 4, 2025

Independent review finds MAHA Report scientifically unsound
Patient Daily | Aug 4, 2025

Founder of ReKlaim Health on 340B: ‘They pocket the difference, bill insurers and patients full price and call it charity care’

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns